SIBN News and Press, SI-BONE Inc.

2026-02-23 19:05:52 ET More on SI-BONE SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript SI-BONE GAAP EPS of -$0.04 beats by $0.08, revenue of $56.3M in-line Seeking Alpha’s Quant Rating on SI-BONE Historical earnings data for SI-BONE Finan...

2026-02-23 19:04:59 ET SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call February 23, 2026 4:30 PM EST Company Participants Saqib Iqbal - Vice President of Financial Planning & Analysis and Investor Relations Laura Francis - CEO & Director Anshul Maheshwari - Chie...

2026-02-23 18:14:17 ET Image source: The Motley Fool. Monday, Feb. 23, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-23 16:24:39 ET More on SI-BONE Seeking Alpha’s Quant Rating on SI-BONE Historical earnings data for SI-BONE Financial information for SI-BONE Read the full article on Seeking Alpha For further details see: SI-BONE GAAP EPS of -$0.04...

Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025 Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinic...

Controladora Vuela Compania de Aviacion S.A.B. de C.V. American Depositary Shares each representing ten (10) Ordinary Participation Certificates (VLRS) is expected to report $0.25 for Q4 2025 Galapagos NV (GLPG) is expected to report $1 for Q4 2025 Octave Specialty Group Inc. (OSG) is exp...

SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming TD Cowen 46th Annual He...

SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended De...

SANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced its preliminary and unaudited revenue and cash and cash equivalents for fourth...

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler 37 th Annual Healthcare Conference in New York, NY. Ma...